Anheuser-Busch Inbev

Q2 FY24 – overly reserved outlook

01/08/24 -"Primarily due to the weak performance in China, ABI missed top-line expectations. Although ABI stabilised its market share in the US during Q2, an upturn in market share is not yet apparent. Thanks ..."

PDF page sample
Pages
50
Language
English
Published on
01/08/24
Download
You may also be interested by these reports :
20/02/26
Danone reported an organic growth of 4.5%, marginally exceeding the 4.4% consensus. Recent infant formula recalls in Europe and the Middle East ...
19/02/26
Pernod Ricard reported a 5.9% organic decline in H1 2026, slightly below expectations, primarily due to weak consumer sentiment in China and ...
19/02/26
Despite the company delivering results largely in line with expectations, with top-line organic growth at 3.5% compared to the consensus forecast of ...
18/02/26
We have revised our projections upward for EBITDA in both FY26 and FY27, leading to an EBITDA average upward revision. For FY26, the updated outlook ...

EXECUTIVE SUMMARY

Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO